Additional studies indicated that current clinical treatment utilizing statins to target hypercholesterolemia has impacted Rac activity in a manner that alters the composition of atherosclerotic plaque beyond simply modulating cholesterol synthesis. The gene discussed is AKT1; the disease is Hypercholesterolemia.